Chinese Vaccine Approved for Human Testing at Virus Epicenter
Hong Kong-listed CanSino Biologics worked with China military
Testing on 108 people to continue through end of this year
We’re tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
CanSino Biologics Inc. said it received Chinese regulatory approval to start human trials of a vaccine against the novel coronavirus, another example of a potential weapon against the illness being fast-tracked for testing as the global death toll escalates and nations impose lockdowns on their citizens.